[go: up one dir, main page]

MA34795B1 - SOLID PHARMACEUTICAL COMPOSITION FOR BUCCAL ADMINISTRATION OF AGOMELATIN - Google Patents

SOLID PHARMACEUTICAL COMPOSITION FOR BUCCAL ADMINISTRATION OF AGOMELATIN

Info

Publication number
MA34795B1
MA34795B1 MA35131A MA35131A MA34795B1 MA 34795 B1 MA34795 B1 MA 34795B1 MA 35131 A MA35131 A MA 35131A MA 35131 A MA35131 A MA 35131A MA 34795 B1 MA34795 B1 MA 34795B1
Authority
MA
Morocco
Prior art keywords
pharmaceutical composition
agomelatin
solid pharmaceutical
buccal administration
buccal
Prior art date
Application number
MA35131A
Other languages
French (fr)
Inventor
Tharrault Froncois
Poirier Cecile
Fonknechten Gilles
Pean Jean-Manuel
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Priority to MA35131A priority Critical patent/MA34795B1/en
Publication of MA34795B1 publication Critical patent/MA34795B1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'INVENTION A POUR OBJET UNE COMPOSITION PHARMACEUTIQUE BUCCALE SOLIDE CONTENANT DE L'AGOMÉLATINE DESTINÉE À UNE ACTION SYSTÉMIQUE.The object of the INVENTION IS A SOLID ORAL PHARMACEUTICAL COMPOSITION CONTAINING AGOMATININE FOR SYSTEMIC ACTION.

MA35131A 2012-08-07 2012-08-07 SOLID PHARMACEUTICAL COMPOSITION FOR BUCCAL ADMINISTRATION OF AGOMELATIN MA34795B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MA35131A MA34795B1 (en) 2012-08-07 2012-08-07 SOLID PHARMACEUTICAL COMPOSITION FOR BUCCAL ADMINISTRATION OF AGOMELATIN

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA35131A MA34795B1 (en) 2012-08-07 2012-08-07 SOLID PHARMACEUTICAL COMPOSITION FOR BUCCAL ADMINISTRATION OF AGOMELATIN

Publications (1)

Publication Number Publication Date
MA34795B1 true MA34795B1 (en) 2014-01-02

Family

ID=50070160

Family Applications (1)

Application Number Title Priority Date Filing Date
MA35131A MA34795B1 (en) 2012-08-07 2012-08-07 SOLID PHARMACEUTICAL COMPOSITION FOR BUCCAL ADMINISTRATION OF AGOMELATIN

Country Status (1)

Country Link
MA (1) MA34795B1 (en)

Similar Documents

Publication Publication Date Title
EP3548000A4 (en) PHARMACEUTICAL COMPOSITIONS OF ATROPINE
EP3222278C0 (en) USE OF AZELNIDIPINE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION INDICATED FOR THE TREATMENT OF CANCER
EP2868667A4 (en) ANTI-BMP9 ANTIBODY-BASED THERAPEUTIC AGENT AS AN ACTIVE INGREDIENT FOR THE TREATMENT OF ANEMIA, INCLUDING RENAL ANEMIA AND CANCER-RELATED ANEMIA
EP3446726A4 (en) EXPECTORATION ASPIRATION TUBE FOR ORAL CARE
EP2869784A4 (en) ORAL APPARATUS FOR THE ADMINISTRATION OF A MEDICAMENT
MA49947A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-BETA-AMYLOID ANTIBODIES
MA49116A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING INSULIN
EP2875826A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF A SEPSIE
EP3505161A4 (en) SUBLINGUAL PHARMACEUTICAL COMPOSITION OF EDARAVONE AND (+) - 2-BORNEOL
MA56049A (en) STABILIZED FORMULATIONS CONTAINING ANTI-ANGPTL3 ANTIBODIES
EP2938332A4 (en) LIPID PRECONCENTRATE OF PROLONGED RELEASE GNRH ANALOGS AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
EP3325080A4 (en) METHODS FOR ENHANCED DELIVERY OF ACTIVE INGREDIENTS TO TUMORS
IN2012DE00912A (en)
EP2842546A4 (en) UNITARY STRUCTURE-TYPE PHARMACEUTICAL COMPOSITION FOR NUCLEIC ACID ADMINISTRATION
EP2394648A4 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
MA52154A (en) PHARMACEUTICAL COMPOSITION FOR ANEMIA
EP3509573A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE DELIVERY OF A PEPTIDE
EP2509635A4 (en) INCREASED GASTRIC RESIDENCE TIME PHARMACEUTICAL COMPOSITIONS USED FOR PROLONGED RELEASE OF POLYPEPTIDES
EP2857007A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING VERBENONE DERIVATIVE FOR THE TREATMENT OR PREVENTION OF NEURODEGENERATIVE DISEASE
MA55362A (en) STABILIZED FORMULATIONS CONTAINING ANTI-IL-33 ANTIBODIES
MA40781A (en) PHARMACEUTICAL COMPOSITION OF LOW DOSAGE ISOTRETINOIN FOR ORAL USE
EP3347099A4 (en) CYCLOPHOSPHAMIDE ANALOGS FOR USE AS IMMUNOGENS AND ASSAY CONJUGATES FOR AN IMMUNOLOGICAL ASSAY OF CYCLOPHOSPHAMIDE AND IFOSFAMIDE
EP2611437A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
EA201200485A1 (en) ORAL FALLING PHARMACEUTICAL DRUG FORM CONTAINING AIPIPRAZOL
MA45158A (en) PHARMACEUTICAL COMPOSITION CONSISTING OF ÉTEPLIRSEN